Reply to comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study".
Potenza
M N
MN
McDougle
C J
CJ
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000188:drug therapy* / Q000523:psychology; D002675:Child, Preschool; D006801:Humans; D000077152:Olanzapine; D010865:Pilot Projects; D010890:Pirenzepine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D015430:Weight Gain
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine